Patrick Driscoll

Patrick Driscoll

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech. producing worldwide market analyses for my audience of medical technology companies, VCs, angels, and other stakeholders.

Website: http://blog.mediligence.com
LinkedIn: https://www.linkedin.com/in/patrickdriscoll
Twitter: https://twitter.com/medmarket
Member since July 31, 2015
  • About
Education
1981 University of Dallas , BA , Molecular Biology
1990 UNH Whittemore School of Business and Economics , MBA , Business
Companies I've founded or co-founded:
MedMarket Diligence, LLC, Medtech Insight, LLC
Companies I work or worked for:
MedMarket Diligence, LLC, Medtech Insight, LLC, Medical Data International, Inc., Biomedical Business International, Genome Therapeutics, Wadley Institutes of Molecular Medicine
If you're an entrepreneur or corporate innovator, why?

I want to be my own boss, and be in control.

What's most frustrating and rewarding about entrepreneurship/innovation?

The most rewarding aspect is conceiving and building product, then driving it to a revenue stream. Since I am painfully impatient, the most frustrating is that entrepreneurs can think and act on ideas immediately, but have to wait for the bureaucracy of other companies.

What's the No. 1 mistake entrepreneurs/innovators make?

Overrate their own value in the endeavor.

What are the top three lessons you've learned as an entrepreneur?

1. Watch your cash.
2. Know the rate-limiting step in your process and accommodate it or change it. Revisit this often, because things change.
3. Trust your instincts.

Full bio

For my publications, I have a small staff and a network of industry insiders to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.